Difficulty
breathing is cardiac
disease main symptom, is certain the major clinical manifestations
of lung disease, timely, accurate to make a difficulty breathing the
differential diagnosis sometimes very difficult, need to use a series of
inspection. So, looking for a quick identification difficulty breathing the
specificity of the index is especially important. BNP precursor no biological
activity, good stability, long half-life, plasma concentrations of high, at the
same time also is a kind of very important heart markers of congestive heart
failure diagnosis is of high sensitivity and specificity.
When the acute respiratory difficulty on admission, it is difficult to judge the primary causes of difficulty breathing, in time for the correct treatment difficult, it is easy to attend, directly affecting the outcome even life patients. Use BNP identify can be found after the main treatment more targeted. A number of studies confirm BNP precursor objective evaluation can be sensitive patients with cardiac function, the early finding no symptoms and clinical heart failure patients, identify whether a patient with hypertension and heart involvement in patients with acute coronary syndrome risk stratification. BNP as a new new function test index, can accurate timely identify cardiac difficulty breathing ,shorten the suspected patients of diagnose time, reducing costs, even improve outcome, and improve the acute respiratory difficulty patients' overall management and treatment level, is a very good screening, diagnosis and prognosis index.
Perlong medical equipment company's BNP precursor detection kit on the market have great share, by the department of hospital welcome, excellent performance.
Therefore, plasma BNP should be a precursor to the acute dyspnoea routine screening of patients. And the precursor of BNP high concentration, good stability, using simple immune chromatography, and can be used for emergency items for future clinical doctors quickly identify cardiac ,simple and reliable method, thus the correct guiding treatment, the practical value bigger, is worthy to be popularized.
When the acute respiratory difficulty on admission, it is difficult to judge the primary causes of difficulty breathing, in time for the correct treatment difficult, it is easy to attend, directly affecting the outcome even life patients. Use BNP identify can be found after the main treatment more targeted. A number of studies confirm BNP precursor objective evaluation can be sensitive patients with cardiac function, the early finding no symptoms and clinical heart failure patients, identify whether a patient with hypertension and heart involvement in patients with acute coronary syndrome risk stratification. BNP as a new new function test index, can accurate timely identify cardiac difficulty breathing ,shorten the suspected patients of diagnose time, reducing costs, even improve outcome, and improve the acute respiratory difficulty patients' overall management and treatment level, is a very good screening, diagnosis and prognosis index.
Perlong medical equipment company's BNP precursor detection kit on the market have great share, by the department of hospital welcome, excellent performance.
Therefore, plasma BNP should be a precursor to the acute dyspnoea routine screening of patients. And the precursor of BNP high concentration, good stability, using simple immune chromatography, and can be used for emergency items for future clinical doctors quickly identify cardiac ,simple and reliable method, thus the correct guiding treatment, the practical value bigger, is worthy to be popularized.
没有评论:
发表评论